Evidence map›Paper›PMID 42464781›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2026

Unlocking Phthalonitrile-Based Type I Photosensitizer Through D-A Modulation to Promote Electron Transfer.

Xia Ling, Zhiyao Li, Chongzhi Wu, Yufu Tang, Zesen Lin, Siqin Chen, Wentao Song, Bowen Li, Bin Liu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xia LingDepartment of Chemical and Biomolecular Engineering, National University of Singapore, Singapore, Singapore.ORCID https://orcid.org/0000-0001-6905-8524
Zhiyao LiSchool of Pharmacy, Anhui Medical University, Hefei, China.
Chongzhi WuSchool of Pharmacy, Anhui Medical University, Hefei, China.
Yufu TangDepartment of Chemical and Biomolecular Engineering, National University of Singapore, Singapore, Singapore.ORCID https://orcid.org/0000-0002-1882-5903
Zesen LinDepartment of Chemical and Biomolecular Engineering, National University of Singapore, Singapore, Singapore.ORCID https://orcid.org/0000-0003-3876-9221
Siqin ChenDepartment of Chemical and Biomolecular Engineering, National University of Singapore, Singapore, Singapore.
Wentao SongDepartment of Chemical and Biomolecular Engineering, National University of Singapore, Singapore, Singapore.
Bowen LiSchool of Pharmacy, Anhui Medical University, Hefei, China.ORCID https://orcid.org/0000-0003-1550-4087
Bin LiuDepartment of Chemical and Biomolecular Engineering, National University of Singapore, Singapore, Singapore.ORCID https://orcid.org/0000-0002-0956-2777

Funding

Anhui Medical University 900206Research Foundation Investigatorship A-80022590000Tan Chin Tuan Centennial Professorship E-467-00-0012-02
6 · The paper itself

Abstract

Type І photosensitizers (PSs) offer a promising strategy to overcome tumor hypoxia in photodynamic therapy (PDT) owing to their minimal oxygen dependence. However, their rational design remains elusive due to insufficient understanding of structure-property relationships. Herein, we leverage donor-π bridge-acceptor (D-π-A) conjugate modulation to design phthalonitrile-based Type І PSs through the systematic regulation of four critical parameters, including ΔE

Indexed as

NitrilesPhotosensitizing AgentsAnimalsCell Line, TumorElectron TransportHumansMiceNanoparticlesPhotochemotherapyReactive Oxygen SpeciesNitrilesPhotosensitizing AgentsReactive Oxygen SpeciesD‐A modulationelectron transferhypoxic tumor therapyphthalonitriletype І photosensitizer

Identifiers

PMID42464781
PMCPMC13496045

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.